Heparin Prophylaxis Dosing for Antepartum Hospitalizations (HEPDOSE)

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

December 15, 2020

Primary Completion Date

March 31, 2022

Study Completion Date

May 1, 2022

Conditions
Pregnancy RelatedAntepartum DVT
Interventions
DRUG

Standard Dose of Unfractionated Heparin

5,000 units subcutaneous unfractionated heparin every 12 hours

DRUG

Gestational Age-Based Dose of Unfractionated Heparin

"* First trimester (\< 14 weeks of gestation): 5,000 units subcutaneous unfractionated heparin every 12 hours~* Second trimester (14-28 weeks of gestation): 7,500 units subcutaneous unfractionated heparin every 12 hours~* Third trimester (\> 28 weeks of gestation): 10,000 units subcutaneous unfractionated heparin every 12 hours"

Trial Locations (1)

90095

UCLA Medical Center, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT04635839 - Heparin Prophylaxis Dosing for Antepartum Hospitalizations (HEPDOSE) | Biotech Hunter | Biotech Hunter